- ►annals.org CC Wee, RS Phillips, G Aurigemma, S … - Annals of internal …, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Background: Because uncontrolled
echocardiographic surveys suggested that up to 30% to 38% of users of fenfluramine and ... Cited by 40 - Related articles - BL Direct - All 7 versions
LB Cannistra, AJ Cannistra - The New England Journal of Medicine, 1998 - nejm.highwire.org To the Editor: Treatment with the appetite-suppressant drugs fenfluramine and
dexfenfluramine, alone or in combination with phentermine, has been associated with
cardiac-valve abnormalities. 1 , 2 , 3 Five echocardiologic surveys reviewed by the Food ... Cited by 30 - Related articles - All 5 versions
MK Kancherla, HI Salti, TA Mulderink, M Parker, RO … - The American journal of …, 1999 - Elsevier We evaluated the prevalence of valvular regurgitation in patients who have taken anorectic
medications. Two-dimensional echocardiograms with color flow Doppler were recorded in 200
consecutive patients referred to a major metropolitan hospital for evaluation of cardiac ... Cited by 24 - Related articles - BL Direct - All 7 versions
DH Ryan, GA Bray, F Helmcke, G Sander, J … - Obesity research, 1999 - ncbi.nlm.nih.gov OBJECTIVE: The prevalence of cardiac valvular regurgitation demonstrated by echocardiography
in patients who took appetite-suppressant medication for weight loss has been assessed at
5%-30%. We studied 86 patients who had echocardiograms before treatment with ... Cited by 47 - Related articles - BL Direct - All 3 versions
- ►annals.org [PDF] ST Mast, JG Jollis, T Ryan, KJ Anstrom, JL … - Annals of internal …, 2001 - Am Coll Physicians Background: An association between the dietary suppressants fenfluramine and dexfenfluramine
and valvular heart disease was first described in patients from North Dakota and Minnesota in
1997. Limited data are available on the natural history of this valvulopathy after ... Cited by 46 - Related articles - BL Direct - All 8 versions
… , HM Connolly, M Grogan, FA Miller - Mayo Clinic …, 2000 - mayoclinicproceedings.com OBJECTIVE: To describe the prevalence of diet drug-related valvular disease among our referral
population and the association of valvular disease with duration of exposure to fenfluramine
and phentermine in combination and to dexfenfluramine alone. PATIENTS AND ... Cited by 16 - Related articles - BL Direct - All 10 versions
DD Hensrud, HM Connolly, M Grogan, … - Mayo Clinic …, 1999 - mayoclinproc.highwire.org OBJECTIVE: To determine the echocardiographic changes over time of valvular heart lesions
in patients who took the weight loss drugs fenfluramine and phentermine. SUBJECTS AND
METHODS: This prospective cohort study began at the termination of a randomized, ... Cited by 48 - Related articles - BL Direct - All 11 versions
- ►ahajournals.org [PDF] JG Jollis, CK Landolfo, J Kisslo, GD Constantine, KD … - Circulation, 2000 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... Effect of Treatment Duration on Prevalence of Valve Abnormalities Cited by 71 - Related articles - BL Direct - All 8 versions
- ►onlinejacc.org AJ Burger, HB Sherman, MJ Charlamb, J Kim, LA … - Journal of the American …, 1999 - Elsevier Early reports have suggested that the use of phen-fen for weight loss may be associated with
increased valvular heart disease. Such reports were based on small numbers of patients, limited
data on dose and duration of phen-fen therapy, and no correlation with matched controls. Cited by 56 - Related articles - BL Direct - All 12 versions
- ►onlinejacc.org NJ Weissman, JF Tighe, JS Gottdiener, JT Gwynne - Journal of the American …, 1999 - Elsevier We previously reported the results of a randomized, double-blind, placebo-controlled trial of
valvular structure and function in 1,073 patients treated either with Dexfen, with an investigational
sustained-release dexfenfluramine (Dexfen SR), or with a placebo, with echocardiograms ... Cited by 22 - Related articles - BL Direct - All 10 versions
